171 related articles for article (PubMed ID: 8221626)
1. Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line.
Chow VT; Quek HH; Tock EP
Cancer Lett; 1993 Sep; 73(2-3):141-8. PubMed ID: 8221626
[TBL] [Abstract][Full Text] [Related]
2. The gene encoding the p53-regulated inhibitor of cdks (pic1) is not expressed in the molt-4 leukemia-cell line with p53 truncated at the carboxyl-terminus, and harbors a nucleotide substitution at codon-31 in several other cancer cell-lines.
Chow V; Ang W
Int J Oncol; 1995 Apr; 6(4):871-6. PubMed ID: 21556614
[TBL] [Abstract][Full Text] [Related]
3. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
4. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia.
Jonveaux P; Berger R
Leukemia; 1991 Oct; 5(10):839-40. PubMed ID: 1961018
[TBL] [Abstract][Full Text] [Related]
5. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.
Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH
Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541
[TBL] [Abstract][Full Text] [Related]
6. The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate.
Tan JM; Tock EP; Chow VT
Mol Pathol; 2003 Apr; 56(2):109-15. PubMed ID: 12665628
[TBL] [Abstract][Full Text] [Related]
7. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
[TBL] [Abstract][Full Text] [Related]
9. p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts.
Magnusson KP; Sandström M; Ståhlberg M; Larsson M; Flygare J; Hellgren D; Wiman KG; Ljungquist S
Gene; 2000 Apr; 246(1-2):247-54. PubMed ID: 10767546
[TBL] [Abstract][Full Text] [Related]
10. Splicing mutations of the p53 gene in human hepatocellular carcinoma.
Lai MY; Chang HC; Li HP; Ku CK; Chen PJ; Sheu JC; Huang GT; Lee PH; Chen DS
Cancer Res; 1993 Apr; 53(7):1653-6. PubMed ID: 8384081
[TBL] [Abstract][Full Text] [Related]
11. Dissemination and tissue invasiveness in murine acute leukemia associated with acquisition of p53 mutation and loss of wild-type p53.
Hsiao M; Wu CY; Low J; Pattengale P; Yeargin J; Haas M
Mol Carcinog; 1995 Jun; 13(2):112-21. PubMed ID: 7605579
[TBL] [Abstract][Full Text] [Related]
12. The c-erbA beta thyroid hormone receptor. Expression and cDNA sequence analysis of the hormone-binding domain in human cancer cell lines.
Chow VT; Lim SS; Tock EP
Acta Oncol; 1994; 33(5):499-505. PubMed ID: 7917362
[TBL] [Abstract][Full Text] [Related]
13. Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line.
Law JC; Ritke MK; Yalowich JC; Leder GH; Ferrell RE
Leuk Res; 1993 Dec; 17(12):1045-50. PubMed ID: 8246608
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing in the first nucleotide binding fold of CFTR.
Will K; Stuhrmann M; Dean M; Schmidtke J
Hum Mol Genet; 1993 Mar; 2(3):231-5. PubMed ID: 7684642
[TBL] [Abstract][Full Text] [Related]
15. A novel transcript encoded within the 10-kb first intron of the human p53 tumor suppressor gene (D17S2179E) is induced during differentiation of myeloid leukemia cells.
Reisman D; Bálint é ; Loging WT; Rotter V; Almon E
Genomics; 1996 Dec; 38(3):364-70. PubMed ID: 8975713
[TBL] [Abstract][Full Text] [Related]
16. P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.
Yeargin J; Cheng J; Yu AL; Gjerset R; Bogart M; Haas M
J Clin Invest; 1993 May; 91(5):2111-7. PubMed ID: 8486778
[TBL] [Abstract][Full Text] [Related]
17. p53 protein accumulation and gene mutations in human glioma cell lines.
Anker L; Ohgaki H; Ludeke BI; Herrmann HD; Kleihues P; Westphal M
Int J Cancer; 1993 Dec; 55(6):982-7. PubMed ID: 8253536
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the TSC2 gene: analysis of the complete coding sequence using the protein truncation test (PTT).
van Bakel I; Sepp T; Ward S; Yates JR; Green AJ
Hum Mol Genet; 1997 Sep; 6(9):1409-14. PubMed ID: 9285776
[TBL] [Abstract][Full Text] [Related]
19. Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.
Takahashi T; D'Amico D; Chiba I; Buchhagen DL; Minna JD
J Clin Invest; 1990 Jul; 86(1):363-9. PubMed ID: 2164047
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of transcript mutations due to transcriptional slippage in rat p53 tumor suppressor gene with the use of yeast functional assay].
Ba Y
Hokkaido Igaku Zasshi; 1999 May; 74(3):173-88. PubMed ID: 10422562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
